Hemoglobinopathies Market is Expected To Reach Over $15.7 Billion by 2028

 

Hemoglobinopathies Market Growth & Trends

The global hemoglobinopathies market size is expected to reach USD 15.7 billion by 2028, according to a new report by Grand View Research, Inc. It is expected to expand at a CAGR of 10.8% from 2021 to 2028. Increasing awareness regarding hemoglobinopathies and government initiatives to diagnose the diseases at an early stage are expected to propel the market growth over the forecast period. Moreover, increasing R&D investment, the presence of a promising drug pipeline, and technologically advanced diagnostics platforms are expected to boost the growth of the market.

The development of novel curative technologies, such as CRISPR/Cas9 and hematopoietic stem cell transplantation, coupled with a promising pipeline, is expected to propel market growth. Moreover, the presence of regulatory agencies, such as the FDA, which are working toward improving drug approval rate by granting accelerated approval for hemoglobinopathies drugs, is expected to drive the market. For instance, in 2019, the FDA has approved four novel drugs: Reblozyl by Bristol-Myers Squibb Company, Adakveo by Novartis AG, Zynteglo by bluebird bio, Inc., and Oxbryta by Global Blood Therapeutics, Inc. for the treatment of hemoglobinopathies.

Initiatives such as the Sickle Cell Awareness Initiative (SCAI) are working toward educating the people about the disease, which will increase the diagnosis and treatment rate. SCAI also raises funds for individuals affected with sickle cell diseases (SCDs) and provides research funding. Moreover, governments of Middle Eastern and Asian countries provide funds for R&D of hemoglobinopathies treatment. For instance, various programs undertaken by governments, such as thalassemia screening in neonates and providing medicines, are impacting the market growth positively.

The high patient population in low-income countries has encouraged market players and non-profit organizations to launch several initiatives to improve the access to the therapy. For instance, in February 2019, the Access to Excellent Care for Sickle Cell Patients Pilot Program (ACCEL) was launched by Global Blood Therapeutics, Inc. in order to provide research funding for novel SCD projects, with an aim to expand the access to optimal healthcare for sickle cell disease.

Biopharmaceutical companies are collaborating with nonprofit organizations to promote public awareness about hemoglobinopathies. For instance, in June 2018, the Sickle Cell Disease Association of America partnered with Emmaus Life Sciences, Inc. to provide online educational tools to sickle cell patients, friends, clinicians, caregivers, and researchers for spreading awareness about complications associated with SCD.

An increase in investment and funding for the development of novel therapies to treat hemoglobinopathies will further boost the market growth over the forecast period. The National Heart, Lung, and Blood Institute (NHLBI) has significantly invested in research & development in sickle cell disease. The NHLBI supports research work through various initiatives. Furthermore, private funding such as the Bronx Blood Research Fund (BBRF) provides a platform for research and management of thalassemia and other hemoglobinopathies.

Gene therapy has emerged as a promising treatment option for managing hemoglobin disorder as it targets the underlying genetic cause of the condition through the administration of one-time gene therapy and significantly reduces the need for blood transfusions. The current pipeline of gene therapy products includes CTX001 (CRISPR Therapeutics), BIVV003 (Sangamo Therapeutics, Inc. & Bioverativ Inc), and HGB-206 (bluebird bio, Inc).

Request a free sample copy or view report summary: Hemoglobinopathies Market Report

Hemoglobinopathies Market Report Highlights

• Based on type, sickle cell disease accounted for the largest share of 56.6% in 2020 and is anticipated to maintain its lead over the forecast period
• The newborn patient population with sickle cell anemia is anticipated to reach 400,000 by 2050. Half of the global sickle cell anemia burden is present in India, Nigeria, and the Democratic Republic of the Congo
• By therapy, in the thalassemia segment, the blood transfusion segment held the largest market share in 2020 and is estimated to dominate the market throughout the forecast period
• Asia Pacific is expected to witness the fastest growth over the forecast period owing to a large potential patient base and high unmet medical needs in the region
• North America held the largest market share in 2020 due to government initiatives focusing on the development of new therapies and better reimbursement scenario

Hemoglobinopathies Market Segmentation

Grand View Research has segmented the global hemoglobinopathies market on the basis of type, diagnosis, therapy, and region:

Hemoglobinopathies Type Outlook (Revenue, USD Million, 2017 - 2028)

• Thalassemia
• Sickle Cell Disease
• Other Hemoglobin (Hb) Variants

Hemoglobinopathies Diagnosis Outlook (Revenue, USD Million, 2017 - 2028)

• Thalassemia
  • Blood Test
  • Genetic Test
  • Prenatal Genetic Test
  • Pre-implantation Genetic Diagnosis
  • Electrophoresis
  • Others
• Sickle Cell Disease
  • Blood Test
  • Genetic Test
  • Prenatal Genetic Test
  • Electrophoresis
  • Others
• Other Hemoglobin (Hb) Variants
  • Blood Test
  • Genetic Test
  • Prenatal Genetic Test
  • Electrophoresis
  • Others

Hemoglobinopathies Therapy Outlook (Revenue, USD Million, 2017 - 2028)

• Thalassemia
  • Blood Transfusion
  • Iron Chelation Therapy
  • Bone Marrow Transplant
  • Others
• Sickle Cell Disease
  • Blood Transfusion
  • Hydroxyurea
  • Bone Marrow Transplant
  • Others
• Other Hemoglobin (Hb) Variants
  • Blood Transfusion
  • Hydroxyurea
  • Iron Chelation Therapy
  • Bone Marrow Transplant
  • Others

Hemoglobinopathies Regional Outlook (Revenue, USD Million, 2017 - 2028)

• North America
  • US.
  • Canada
• Europe
  • UK.
  • Germany
  • France
  • Italy
  • Spain
  • Russia
• Asia Pacific
  • India
  • China
  • Japan
  • Singapore
  • Australia
  • South Korea
• Latin America
  • Argentina
  • Brazil
  • Mexico
• Middle East & Africa
  • Saudi Arabia
  • United Arab Emirates
  • South Africa

List of Key Players of Hemoglobinopathies Market

• Sangamo Therapeutics, Inc.
• Global Blood Therapeutics, Inc.
• bluebird bio, Inc.
• Emmaus Life Sciences Inc.
• Pfizer, Inc.
• Novartis AG
• Prolong Pharmaceuticals, LLC
• Bioverativ Inc.
• Gamida Cell

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Specialty Medical Chairs Market Is Expected To Gain Significant Traction Over The Forecast Period

 Specialty Medical Chairs Market Growth & Trends

The global specialty medical chairs market size is expected to reach USD 6.05 billion by 2028 registering a CAGR of 7.5%, according to a new report by Grand View Research, Inc. Increasing geriatric population is one of the major factors boosting the product adoption. As per the WHO, it is estimated that from 2025 to 2050, the older population is expected to almost double to 1.6 billion globally. According to The World Bank, the population in the Asia Pacific region is aging rapidly.

More than 211 million people aged 65 years and above were living in East Asia and Pacific in 2010. The older population is expected to grow by 22% every five years in East Asia. This shows the potential demand for geriatric chairs in the coming years. The rising prevalence of lifestyle-associated diseases, such as diabetes, obesity, chronic kidney disease, and Cardiovascular Diseases (CVDs), is also expected to augment the product demand. Furthermore, rising cases of paralysis and spinal injuries are anticipated to contribute to the market growth.

Increasing reimbursement policies and supportive regulatory frameworks in developed nations are also pushing the market growth. For instance, Medicare policies in the U.S. offer reimbursement for equipment, such as wheelchairs, recliners, and others. In addition, key market players are offering customized products to meet the various needs of doctors and patients. Rising demand for new, easy-to-use products with better facilities is expected to provide lucrative opportunities to the market participants.

The examination and treatment rate at dental, ophthalmic, and gynecology clinics has decreased significantly, which can be attributed to the lockdown imposed in various Asian countries due to the pandemic and growing preference for online consultations. Various domestic and international companies are facing major challenges in Japan and China due to the pandemic and the aftermath is expected to continue until the second half of 2021.

Moreover, the healthcare resources are currently directed toward essential medical devices and supplies. It is believed that the outbreak will lead to many changes, including preferences of the general public, leading to a decline in product demand. However, major countries in Asia, such as China and South Korea, are on a steady path to recovery. According to the Asian Development Bank, China’s growth is expected to rebound by about 7.3% by 2021.

Request a free sample copy or view report summary: Specialty Medical Chairs Market Report

Specialty Medical Chairs Market Report Highlights

• The rehabilitation product segment held the dominant share of over 40% in 2020 owing to rise in the geriatric population
• In 2020, dialysis chairs held the largest share in the examination product segment owing to the increased prevalence of chronic kidney diseases and rise in funding to centers for better equipment
• The treatment product segment is anticipated to register the fastest CAGR over the forecast period as these products are required for carrying out various treatment procedures, such as dental, and offer better comfort to patients during these procedures
• Asia Pacific is anticipated to be the fastest-growing regional market from 2021 to 2028 owing to improving healthcare infrastructure, growing geriatric population, and rising disposable income levels

Specialty Medical Chairs Market Segmentation

Grand View Research has segmented the global specialty medical chairs market on the basis of product and region:

Specialty Medical Chairs Product Outlook (Revenue, USD Million, 2016 - 2028)

• Examination
  • Birthing
  • Cardiac
  • Blood Drawing
  • Dialysis
  • Mammography
• Treatment
  • Ophthalmic
  • ENT
  • Dental
  • Others
• Rehabilitation
  • Pediatric
  • Bariatric
  • Geriatric
  • Others

Specialty Medical Chairs Regional Outlook (Revenue, USD Million, 2016 - 2028)

• North America
  • US.
  • Canada
• Europe
  • Germany
  • UK.
  • France
  • Italy
  • Spain
• Asia Pacific
  • Japan
  • China
  • India
• Latin America
  • Brazil
  • Mexico
• MEA
  • South Africa
  • Saudi Arabia

List of Key Players of Specialty Medical Chairs Market

• A-dec, Inc.
• ActiveAid, Inc.
• DentalEZ, Inc.
• Fresenius Medical Care AG & Co. KGaA
• Topcon Corp.
• Midmark Corp.
• Danaher (KaVo Dental GmbH)
• Dentsply Sirona
• Planmeca Oy
• Hill Laboratories Company

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Structural Insulated Panels Market is Expected to Amplify USD 17.19 Billion Value by 2028

 Structural Insulated Panels Market Growth & Trends

The global structural insulated panels market size is expected to reach USD 17.19 billion by 2028, according to a new report by Grand View Research, Inc., expanding at a CAGR of 5.5% over the forecast period. Growing emphasis on constructing energy-efficient building structures and the rising investments in the renovation of old buildings are some of the major factors expected to boost the product demand.

Governments across the world are providing various incentives to construction companies and building contractors to promote energy-efficient building structures. For instance, the U.S. government, through its Weatherization Assistance Program (WAP), is incentivizing the improvement of thermal insulation in low-income households, which is expected to promote the demand for structural insulated panels (SIPs).

Key players are focusing on the development of novel insulation materials to improve the R-value of the product without adding to the final cost. For instance, the Kingspan Group has developed a novel insulation material using its proprietary ‘QuadCore Technology’. The product offers superior fire protection and durability. Furthermore, it is 11% and 60% more thermally efficient than high-quality PIR (Polyisocyanurate) and PU (Polyurethane) insulation materials respectively.

Request a free sample copy or view report summary: Structural Insulated Panels Market Report

Structural Insulated Panels Market Report Highlights

• The polyurethane product segment in the North America regional market is expected to register the fastest CAGR of 7.9% over the forecast period owing to superior insulation property, rigidity, fire resistance, and dimensional property of polyurethane
• The cold storage application segment is expected to witness significant growth during the forecast period owing to growing investments in the development of cold chain infrastructure across the globe
• In the Asia Pacific regional market, the polystyrene product segment accounted for the largest revenue share in 2020 owing to high demand for cost-effective, durable insulation materials from the construction industry
• Europe is expected to be the second-largest regional market from 2021 to 2028 owing to the progressive adoption of green building standards and rising investments in the redevelopment of old building structures in the region
• Major companies are offering training and services to the installation workers and building contractors to ensure the correct installation of the product and reduce the chances of product failure

Structural Insulated Panels Market Segmentation

Grand View Research has segmented the global structural insulated panels market on the basis of product, application, and region:

Structural Insulated Panels Product Outlook (Volume, Million Square Feet; Revenue, USD Million, 2017 - 2028)

• Polystyrene
• Polyurethane
• Glass Wool
• Others

Structural Insulated Panels Application Outlook (Volume, Million Square Feet; Revenue, USD Million, 2017 - 2028)

• Walls & Floors
• Roofs
• Cold Storage

Structural Insulated Panels Regional Outlook (Volume, Million Square Feet; Revenue, USD Million, 2017 - 2028)

• North America
  • US.
  • Canada
  • Mexico
• Europe
  • UK.
  • Germany
  • Italy
• Asia Pacific
  • China
  • Japan
  • India
• Central & South America
  • Brazil
  • Argentina
• Middle East & Africa (MEA)
  • UAE

List of Key Players of Structural Insulated Panels Market

• Metl-Span
• Kingspan Group
• PFB Corporation
• Isopan
• KPS Global
• American Insulated Panel
• Structural Panels Inc.
• All Weather Insulated Panels
• Ingreen Systems Corp.
• Owens Corning

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research    reports, customized research reports, and consulting services. To help clients make informed business    decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Preclinical CRO Market to Showcase Healthy Expansion at 8.1% CAGR During 2021 – 2028

 

Preclinical CRO Market Growth & Trends

The global preclinical CRO market size is expected to reach USD 8.4 billion by 2028, according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 8.1% from 2021 to 2028. The market is expected to witness lucrative growth over the forecast period due to increasing R&D expenditure and growing outsourcing trend. The increasing volume of new drugs entering the preclinical phase is also anticipated to boost the market growth over the forecast period.

The market is undergoing a series of mergers and acquisitions, resulting in the improvement in full-service capabilities and international reach of larger companies. For instance, in 2019, WuXi AppTec acquired Pharmapace. On the other hand, mid-sized and smaller contract research organizations (CROs) are focusing on niche sectors and are providing a personalized approach to their sponsors. Various companies are focusing on research and development of new drugs, and therefore are outsourcing these activities to launch efficient CRO services in the market. This, in turn, provides a positive atmosphere for joint ventures among market participants owing to the preference of sponsors to maximize their benefits.

The COVID-19 epidemic is ever increasing since it was first identified in China in December 2019. Until January 20, 2021, more than 96.7 million cases of COVID-19 were reported globally, with more than 2,068,303 deaths across the globe. This pandemic has fast-tracked the development of vaccine and drug testing. There are currently more than 50 COVID-19 vaccine candidates in preclinical studies as well as trials.

North America held the largest share of 47.7% in 2020. Significant investment in healthcare R&D, coupled with well-developed healthcare infrastructure in the U.S., is contributing to the largest share of North America. Asia Pacific is projected to expand at the fastest CAGR of 12.0% over the forecast period.

Request a free sample copy or view report summary: Preclinical CRO Market Report

Preclinical CRO Market Report Highlights

• By service, the toxicology testing segment accounted for the largest share of 61.1% in 2020 due to its significance in Investigational New Drug (IND)-enabling studies
• Based on end-use, the government and academic institutes segment is anticipated to register the highest CAGR of 8.4% over the forecast period due to improving government initiatives toward healthcare, especially in developing economies
• North America dominated the market in 2020 with a share of 47.7%. Significant healthcare expenditure on R&D is one of the major factors driving the market in this region

Preclinical CRO Market Segmentation

Grand View Research has segmented the global preclinical CRO market on the basis of service, end-use, and region:

Preclinical CRO Service Outlook (Revenue, USD Million, 2016 - 2028)

• Bioanalysis and DMPK Studies
• Toxicology Testing
• Others

Preclinical CRO End-use Outlook (Revenue, USD Million, 2016 - 2028)

• Biopharmaceutical Companies
• Government and Academic Institutes
• Medical Device Companies

Preclinical CRO Regional Outlook (Revenue, USD Million, 2016 - 2028)

• North America
  • US.
  • Canada
• Europe
  • UK.
  • Germany
  • France
  • Spain
  • Italy
  • Netherlands
  • Belgium
  • Switzerland
  • Russia
  • Sweden
• Asia Pacific
  • India
  • Japan
  • China
  • Australia
  • South Korea
  • Malaysia
  • Indonesia
  • Singapore
  • Philippines
  • Thailand
• Latin America
  • Brazil
  • Mexico
  • Argentina
  • Columbia
  • Chile
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Israel
  • Egypt

List of Key Players of Preclinical CRO Market

• Envigo Corporation
• MPI research
• Eurofins Scientific
• PRA Health Sciences, Inc.
• Wuxi AppTec
• Medpace, Inc.
• Pharmaceutical Product Development (PPD), LLC
• PARAXEL International Corporation
• ICON Plc
• Laboratory Corporation of America, Inc.

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research    reports, customized research reports, and consulting services. To help clients make informed business    decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Digital Payment Market to Observe Strong Development by 2028

 Digital Payment Market Growth & Trends

The global digital payment market size is expected to reach USD 236.10 billion by 2028, according to a new report by Grand View Research, Inc. It is projected to register a CAGR of 19.4% from 2021 to 2028. The growth can be attributed to the growing volume of non-cash transactions and a rise in the fintech sector's technological developments. Various fintech companies and banks are making efforts to improve their digital offerings to meet the changing needs of customers. For instance, in January 2021, Mogo Inc., a financial technology & digital payment company, announced the shareholder's approval for the acquisition of Carta, a digital payment company. This acquisition is expected to help the former company in strengthening its presence in the market.

Biometric authentication in digital payments is expected to gain momentum in the coming years. It is a verification method that involves the biological characteristics of the person. The verifications include facial recognition, fingerprinting scanning, heartbeat analysis, and vein mapping. According to Payments Industry Intelligence, biometric authentication solutions are expected to be used to secure USD 2.5 trillion worth of mobile payment transactions by 2024.

The increase in the adoption of new technologies such as self-checkout systems in the retail industry is expected to drive market growth. In recent days, various companies are making efforts to deploy self-checkout systems in retail stores. For instance, in June 2020, Walmart, a retail company, announced the testing of its self-checkout retail stores at multiple locations in Arkansas, Fayetteville, during the pandemic. These stores will replace the traditional cashier checkout lanes with self-checkout systems.

The COVID-19 pandemic is anticipated to impact the market growth favorably in the near future. The pandemic has led to an increase in the use of mobile-based payment solutions and online sales, which are some of the major factors driving the demand for digital payment solutions globally. According to the study conducted by Accenture, transactions worth USD 7 trillion are expected to shift from cash to card and digital payments by 2023.

Request a free sample copy or view report summary: Digital Payment Market Report

Digital Payment Market Report Highlights

• In terms of deployment, the on-premise segment dominated the market in 2020. The on-premise deployment of digital payment solutions facilities secured transactions
• In terms of enterprise size, the large enterprise segment dominated the market in 2020. Many large enterprises have adopted digital payment solutions to efficiently manage their payment transactions, improve visibility of transactions, and enhance customer experience by reducing the time required to complete the payment
• In terms of end-use, the BFSI segment dominated the market in 2020. The continued digitalization of banks and other financial institutions is anticipated to drive the growth of the BFSI segment
• The increasing adoption of digital payment solutions in emerging economies such as China and India is expected to create growth opportunities for the market players in the Asia Pacific region over the forecast period

Digital Payment Market Segmentation

Grand View Research has segmented the global digital payment market based on solution, mode of payment, deployment, enterprise size, end-use, and region:

Digital Payment Solution Outlook (Revenue, USD Billion, 2016 - 2028)

• Application Program Interface
• Payment Gateway
• Payment Processing
• Payment Security & Fraud Management
• Transaction Risk Management
• Others

Digital Payment Mode of Payment Outlook (Revenue, USD Billion, 2016 - 2028)

• Bank Cards
• Digital Currencies
• Digital Wallets
• Net Banking
• Point of Sales
• Others

Digital Payment Deployment Outlook (Revenue, USD Billion, 2016 - 2028)

• Cloud
• On-premise

Digital Payment Enterprise Size Outlook (Revenue, USD Billion, 2016 - 2028)

• Large Enterprises
• Small & Medium Enterprises

Digital Payment End-use Outlook (Revenue, USD Billion, 2016 - 2028)

• BFSI
• Healthcare
• IT & Telecom
• Media & Entertainment
• Retail & E-commerce
• Transportation
• Others

Digital Payment Regional Outlook (Revenue, USD Billion, 2016 - 2028)

• North America
  • US.
  • Canada
• Europe
  • Germany
  • UK.
• Asia Pacific
  • China
  • India
  • Japan
• Latin America
  • Brazil
• Middle East & Africa

List of Key Players in the Digital Payment Market

• Aliant Payments
• Aurus Inc.
• Adyen
• Financial Software & Systems Pvt. Ltd.
• PayPal Holdings Inc.
• Novatti Group Pty Ltd.
• ACI Worldwide, Inc.
• Global Payments Inc.
• Wirecard
• Net

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Pharmacy Automation Devices Market to Partake Significant Development During the Forecast Period: Grand View Research Inc.

 

Pharmacy Automation Devices Market Growth & Trends

The global pharmacy automation devices market size is expected to reach USD 9.5 billion by 2028, according to a new report by Grand View Research, Inc. It is expected to expand at a CAGR of 9.3% from 2021 to 2028. The increasing burden of chronic diseases and the growing geriatric population are leading to an increase in the number of prescriptions. This, in turn, is resulting in a rise in the number of medication errors. For instance, 237.4 million medication errors occurred in England in 2018, according to the article published in The Pharmaceutical Journal. This is driving the demand for pharmacy automation devices. Moreover, an increase in initiatives by various organizations, such as the American Society of Health-System Pharmacists, to reduce medication errors is positively impacting the market growth.

In 2020, the medication dispensing systems product segment accounted for the largest revenue share owing to the benefits offered by these products, such as minimized medication errors, better inventory management, improved medication adherence for patients with complex treatments, improved patient care, minimized drug waste with true split-fills, improved storage capacity, and reduced administrative burden among the end-users. The automated medication compounding systems segment is anticipated to witness the fastest growth during the forecast period. Reduction in compounding errors and contamination is a major factor driving the segment. Moreover, the increasing adoption of these devices for sterile compounding is fueling the segment growth.

The retail pharmacy end-use segment accounted for the largest revenue share in 2020. The rising adoption of these solutions, the presence of a large number of retail pharmacies, and growing investments in this sector are driving the segment. For instance, in May 2018, McKesson Co., a Healthcare Information Technology (HIT) company, entered into an agreement with Discount Drug Mart, which is an Ohio-based retail drug store, to build an automated central fill pharmacy. The hospital pharmacy is anticipated to witness the fastest growth during the forecast period owing to the adoption of automated technologies by hospitals. For instance, in February 2020, Geisinger, a health provider in the U.S., partnered with Omnicell, Inc. for the implementation of an automated dispensing system.

In 2020, North America dominated the market. This is attributed to the presence of a large number of industry players, such as BD, Omnicell, Baxter, AmerisourceBergen, and Cerner. The majority of the companies such as BD and Baxter generated more than 50% of sales revenue in the U.S. Asia Pacific is anticipated to witness the fastest growth during the forecast period. Rapid adoption in automated solutions, investments in the adoption of healthcare IT infrastructure, and high healthcare spending are the key factors contributing to the growth of the market. Moreover, initiatives by public and private bodies to reduce medication errors are likely to drive the regional market.

Request a free sample copy or view report summary: Pharmacy Automation Devices Market Report

Pharmacy Automation Devices Market Report Highlights

• The market is driven by various technological advancements and increasing investments in the automation sector
• Based on product, the medication dispensing systems segment dominated the market in 2020 owing to the increasing adoption of these products to avoid errors while dispensing medication
• By end-use, the retail pharmacy segment dominated the market in 2020 owing to high adoption rates of these devices and investments by major retail chains, such as CVS Health and Walgreens
• North America dominated the market in 2020 owing to the presence of a large number of automation companies in the region

Pharmacy Automation Devices Market Segmentation

Grand View Research, Inc. has segmented the global pharmacy automation devices market on the basis of product, end-use, and region:

Pharmacy Automation Devices Product Outlook (Revenue, USD Million, 2016 - 2028)

• Medication Dispensing Systems
• Packaging and Labeling Systems
• Storage and Retrieval Systems
• Automated Medication Compounding Systems
• Tabletop Tablet Counters

Pharmacy Automation Devices End-use Outlook (Revenue, USD Million, 2016 - 2028)

• Hospital Pharmacy
• Retail Pharmacy

Pharmacy Automation Devices Regional Outlook (Revenue, USD Million, 2016 - 2028)

• North America
  • US.
  • Canada
• Europe
  • Germany
  • UK.
  • France
  • Spain
  • Italy
  • Russia
• Asia Pacific
  • Japan
  • China
  • India
  • Australia
  • Singapore
  • South Korea
• Latin America
  • Brazil
  • Mexico
  • Argentina
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

List of Key Players of Pharmacy Automation Devices Market

• Amerisource Bergen Corporation
• Accu Chart Plus Healthcare Systems, Inc.
• Omnicell, Inc.
• McKesson Corporation
• Pearson Medical Technologies, LLC
• Baxter
• Talyst, LLC
• ScriptPro, LLC
• CareFusion (Becton Dickinson And Company)
• Medacist Solutions Group, LLC
• Kirby Lester
• Cerner Corporation
• iA
• ARxIUM
• TouchPoint Medical
• Deenova S.R.L
• Parata Systems, LLC
• Swisslog Healthcare
• Yuyama Co. Ltd.

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Medical Device Analytical Testing Outsourcing Market Expectations Acme Prominent Development in Developed Regions, Details Gvr Study

 

Medical Device Analytical Testing Outsourcing Market Growth & Trends

The global medical device analytical testing outsourcing market size is expected to reach USD 9.7 billion by 2028, according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 7.6% from 2021 to 2028. Numerous medical device companies outsource analytical testing operations to minimize business risks, hasten product market entry, and reduce costs. These procedures lead to a significant rise in expenditure levels and, therefore, original equipment manufacturers of medical instruments rapidly switch to outsourcing as one of the effective cost curbing tools.

Implantable Medical Devices (IMDs) are being used increasingly in order to improve patients’ health outcomes. Designers of IMDs have to balance complexity, reliability, power consumption, and costs. Consequently, companies are shifting their focus to innovation rather than non-core activities and, therefore, outsourcing these activities to launch efficient instruments. All these factors are expected to drive the market over the forecast period.

In this complex ecosystem, it is necessary for the equipment to provide accurate results, to have durability, and easy operation. To match these parameters, devices now have to undergo shear checking in accelerated conditions to obtain marketing approval and have a competitive advantage. Conducting this in-house is a matter of time, labor, and cost; outsourcing these tests helps overcome these limitations. For instance, the ISO 10993 has revised the Analytical Evaluation Threshold (AET) for better toxicological safety assessment. Lack of awareness with regards to these tests among the manufacturers of medical instruments may lead to reworking, which is usually avoided when outsourced to third-parties. Hence it is very important to be aware of AET as regulators will review the analytical report to check whether the AET was followed or not. Also, it is the duty of the medical device manufacturer to ensure that AET is applied to the checking process.

Various companies globally have increased the manufacturing of medical devices such as personal protective equipment (PPE) kits, ventilators, and N-95 masks. This has created opportunities for the players in the Testing, Inspection, and Certification (TIC) Market to test and certify these instruments. Many companies such as TÜV SÜD and Eurofins have started checking these medical instruments, thus increasing the demand for analytical testing services from the healthcare industry. Also with increasing cases of COVID-19 globally, the demand for analytical testing services will surge in the coming months.

Request a free sample copy or view report summary: Medical Device Analytical Testing Outsourcing Market Report

Medical Device Analytical Testing Outsourcing Market Report Highlights

• The material characterization segment dominated the market in 2020 and is likely to grow at a lucrative rate during the forecast period
• Other tests that are inclusive of cleaning, reprocessing, method development and validation, accelerated stability testing, biocompatibility, validation checking for packaging materials (container closure permeation), and transport stability are anticipated to witness the fastest growth over the forecast period
• North America accounted for significant market share owing to the fact that it is one of the top manufacturing hubs of highly reliable, complex, and high-end medical instruments, with the presence of abundant service providers

Medical Device Analytical Testing Outsourcing Market Segmentation

Grand View Research has segmented the global medical device analytical testing outsourcing market based on services, therapeutic areas, device type, end-use, and region:

Medical Device Analytical Testing Outsourcing Services Outlook (Revenue, USD Million, 2016 - 2028)

• Extractable and leachable
• Material characterization
• Physical testing
• Bioburden testing
• Sterility testing
• Other tests

Medical Device Analytical Testing Outsourcing Therapeutic Areas Outlook (Revenue, USD Million, 2016 - 2028)

• Cardiology
• Diagnostic Imaging
• Orthopedic
• IVD
• Ophthalmic
• General & Plastic Surgery
• Drug Delivery
• Endoscopy
• Dental
• Diabetes Care
• Others

Medical Device Analytical Testing Outsourcing Device Type Outlook (Revenue, USD Million, 2016 - 2028)

• Reprocessed Devices
  • Hospital
  • Others
• Others

Medical Device Analytical Testing Outsourcing End-use Outlook (Revenue, USD Million, 2016 - 2028)

• Hospital
  • Equipment
  • Consumables
• Others

Medical Device Analytical Testing Outsourcing Regional Outlook (Revenue, USD Million, 2016 - 2028)

• North America
  • US.
  • Canada
• Europe
  • UK.
  • Germany
• Asia Pacific
  • Japan
  • China
• Latin America
  • Brazil
  • Mexico
• Middle East & Africa
  • South Africa
  • Saudi Arabia

List of Key Players of Medical Device Analytical Testing Outsourcing Market

• SGS SA
• Toxikon, Inc.
• Eurofins Scientific
• Pace Analytical Services, LLC
• Intertek Group plc
• WuXi AppTec.
• NORTH AMERICAN SCIENCE ASSOCIATES INC.
• Envigo
• Charles River Laboratories International Inc.
• Medical Device Testing Services

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Dry Eye Treatment Devices Market to Witness a Pronounce Growth During 2021– 2028

 Dry Eye Treatment Devices Market Growth & Trends

The global dry eye treatment devices market size is estimated to reach USD 414.2 million by 2028, according to a new report by Grand View Research, Inc. It is anticipated to register a CAGR of 6.3% over the forecast period. The increasing demand for targeted, non-invasive, faster, and patient compliant treatment methods to alleviate dry eye symptoms are the factors expected to drive the market growth during the forecast period.

The rising incidence of causative risk factors such as over usage of contact lenses, prolonged exposure to digital screens, diabetes, glaucoma, and Sjogren's syndrome globally is anticipated to propel the growth of the market. For instance, Americans are estimated to spend an average time of more than 10 hours a day at visual display terminals.

The increasing number of clinical and research activities conducted to evaluate the safety and efficacy of advanced dry eye treatment devices such as IPL and BBL will boost market growth. The application of these advanced technologies in eye care is at a nascent stage in many countries, thereby clinical evidence is essential to increase provider confidence over its acceptance. Besides, clinical studies of these technologies are showing promising results in comparison with conventional treatment methods in dry eye treatment.

The availability of alternative treatment, high cost of IPL/BBL treatment, numerous contraindications associated with IPL, and lack of an efficient health insurance policy in several countries are the factors rendering the growth of the dry eye treatment devices market. For instance, the treatment of dry eye syndrome using intense pulsed light (IPL) is not covered under the NHS, a major provider of healthcare service in the U.K.

Request a free sample copy or view report summary: Dry Eye Treatment Devices Market Report

Dry Eye Treatment Devices Market Report Highlights

• The MGX technology held the largest market share in 2020 owing to the factors such as frequent product launches, cost-effectiveness, and improving accessibility
• IPL and Combination (IPL+MGX) technologies are expected to grow at the fastest rate during the forecast period due to the factors such as the development of economical and compact-sized IPL devices having versatility in treating skin tone of all types have boosted its installation rate in clinics and ophthalmic centers
• North America held the largest market share in the market and is anticipated to maintain its dominance over the forecast period, attributable to the growing prevalence of dry eye disease, increasing R&D expenditure, and many ophthalmology trade conferences and expos conducted in the U.S. and Canada
• Some of the prominent companies are Lumenis; ESW Vision; Johnson & Johnson Services, Inc.; MiBo Medical Group; Alcon; and Sight Sciences

Dry Eye Treatment Devices Market Segmentation

Grand View Research has segmented the dry eye treatment devices market based on technology and region:

Dry Eye Treatment Devices Technology Outlook (Volume, Units; Revenue, USD Million, 2016 - 2028)

• Broadband light (BBL)
• Intense Pulsed Light (IPL)
• Meibomian Gland Expression (MGX)
• Combination (MGX+IPL)

Dry Eye Treatment Devices Regional Outlook (Revenue, USD Million, 2016 - 2028)

• North America
  • US.
  • Canada
• Europe
  • Germany
  • UK.
  • France
  • Italy
  • Spain
• Asia Pacific
  • China
  • Japan
  • India
  • Thailand
  • South Korea
• Latin America
  • Brazil
  • Mexico
  • Argentina
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

List of Key Players of the Dry Eye Treatment Devices Market

• MiBo Medical Group
• Sight Sciences
• Lumenis
• ESW Vision
• Johnson & Johnson Vision Care
• Alcon, Inc.

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Active Pharmaceutical Ingredient Market is Expected to Amplify $312.56 Billion Value by 2028: Grand View Research Inc.

 

Active Pharmaceutical Ingredient Market Growth & Trends

The global active pharmaceutical ingredients market size is expected to reach USD 312.56 billion by 2028, according to a new report by Grand View Research, Inc. It is expected to expand at a CAGR of 6.6% from 2021 to 2028. The market is driven by the growth of the biopharmaceutical sector, advancements in active pharmaceutical ingredient (API) manufacturing, and an increase in the geriatric population.

The growth of the captive API segment is propelled by companies investing in solving challenges and developing new chemical ways for the production of APIs in house. This aids in reducing costs and the risk of contamination. Artificial intelligence and protein synthesis are expected to facilitate faster development with greater control over the process.

The rising prevalence of chronic and lifestyle-based conditions, such as cardiovascular diseases, is accelerating the demand for API. For instance, as per U.S. Pharmacist in 2020, 47% of adults have at least one risk factor that supports cardiovascular disease development. Cardiovascular diseases are one of the global, critical public health burdens driving extensive R&D for APIs in the field.

The generic API segment is gaining share in the market owing to its cost effectiveness, which helps in catering to the needs of the rising number of patients in developing regions with a low-income population. According to the Association for Accessible Medicines (AAM), in 2017, there was a considerable rise in manufacturing units in Asia, Australia, and EU5. There has also been an increase in the market share of generic drugs.

Developing nations like India are receiving an increased preference in the market over dominant API market countries, like China, owing to geopolitical situations. Furthermore, other factors favoring India include quality raw materials and products, large workforce, vast distribution network, and government subsidies under schemes like “Make in India”.

For addressing unmet medical needs, companies are collaborating to develop novel treatments. This allows firms to use their resources to aid in the development of products and enhance the supply chain. In August 2019, OmniChem Private Limited was acquired by Ajinomoto Bio-Pharma Services (earlier they were in a joint venture since 2011 for the manufacturing of APIs). The acquisition was completed in June 2020.

Request a free sample copy or view report summary: Active Pharmaceutical Ingredient Market Report

Active Pharmaceutical Ingredient Market Report Highlights

• According to the WHO, around 17.5 million people die each year due to cardiovascular diseases, accounting for 31% of all deaths across the globe
• The growing geriatric population in Asian countries, such as Japan and China, along with high untapped opportunities, is expected to drive the market during the forecast period. It is estimated that over 20% of the Japanese population is aged 65 and above
• According to the CDC, about 795,000 people in the U.S. suffer from stroke every year, out of which 87% cases are of ischemic stroke
• Companies are looking to diversify their API suppliers and manufacturers to different locations instead of outsourcing it to just one manufacturer or country
• Key players are increasingly focusing on vaccines, for instance, Sanofi announced an investment of USD 601.37 million for vaccine production and research in France. These investments are anticipated to drive the development of new vaccine APIs in the coming years to help facilitate readiness to deliver new products

Active Pharmaceutical Ingredient Market Segmentation

Grand View Research has segmented the global active pharmaceutical ingredients market based on type of synthesis, type of manufacturer, type, application, and region:

Active Pharmaceutical Ingredient Type of Synthesis Outlook (Revenue, USD Billion, 2017 - 2028)

• Biotech
  • Monoclonal Antibodies
  • Recombinant Proteins
  • Vaccines
• Synthetic

Active Pharmaceutical Ingredient Type of Manufacturer Outlook (Revenue, USD Billion, 2017 - 2028)

• Captive APIs
• Merchant APIs

Active Pharmaceutical Ingredient Type Outlook (Revenue, USD Billion, 2017 - 2028)

• Generic APIs
• Innovative APIs

Active Pharmaceutical Ingredient Application Outlook (Revenue, USD Billion, 2017 - 2028)

• Cardiovascular Diseases
• Oncology
• CNS and Neurology
• Orthopedic
• Endocrinology
• Pulmonology
• Gastroenterology
• Nephrology
• Ophthalmology
• Others

Active Pharmaceutical Ingredient Regional Outlook (Revenue, USD Billion, 2017 - 2028)

• North America
  • US.
  • Canada
• Europe
  • UK.
  • Germany
  • France
  • Italy
  • Spain
  • Russia
• Asia Pacific
  • Japan
  • China
  • India
  • South Korea
  • Australia
• Latin America
  • Brazil
  • Mexico
  • Argentina
• Middle East & Africa
  • South Africa
  • UAE
  • Saudi Arabia

List of Key Players of Active Pharmaceutical Ingredient Market

• Merck & Co., Inc.
• AbbVie, Inc.
• Bristol-Myers Squibb Company
• Boehringer Ingelheim International GmbH
• Cipla, Inc.
• Teva Pharmaceutical Industries Ltd.
• Albemarle Corporation
• Viatris Inc.
• Aurobindo Pharma
• Sun Pharmaceutical Industries Ltd.
• Reddy’s Laboratories Ltd.

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Veterinary Telehealth Market Latest Innovations, Drivers and Industry Key Events 2021 – 2028

 Veterinary Telehealth Market Growth & Trends

The global veterinary telehealth market size is expected to reach USD 417.1 million by 2028 according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 19.5% from 2021 to 2028. An increase in the adoption of telehealth services among pet owners coupled with the rising prevalence of animal diseases are the key contributors to market growth.

The key advantages of veterinary telehealth such as saving transportation costs and reduction of ancillary expenses are driving the growth of the market. In addition, the doctor’s advice and virtual care can be obtained on an immediate basis. Further, it also saves time as animal caretakers can skip the time consumed during long waiting hours. Such factors are boosting market growth.

There is increased adoption of IoT and AI by farmers and pet parents. This can be attributed to the increase in internet penetration and user-friendly animal healthcare websites or apps. Such factors are anticipated to increase the demand for veterinary telehealth over the forecast period. In addition, increasing cases of zoonotic diseases coupled with the concern of owners about their animal health is also propelling the growth of the market.

Request a free sample copy or view report summary: Veterinary Telehealth Market Report

Veterinary Telehealth Market Report Highlights

• The other animal segment dominated the market with a revenue share of 27.5% in 2020 and is projected to show a CAGR of over 18.0% from 2021 to 2028. High consumption of poultry and cattle products on a daily basis is contributing to the growth of this segment
• The teleconsulting segment dominated the market with a revenue share of 19.6% in 2020 owing to the increasing demand for virtual quality animal healthcare services
• Due to the presence of well-established market players and increasing research and development activities by these players, North America dominated the market as of 2020 with a revenue share of around 37.2%
• However, Asia Pacific is anticipated to show lucrative growth over the forecast period owing to the rising adoption of veterinary telehealth services and increasing livestock population in the region
• Industry players are involved in strategic initiatives such as acquisitions and mergers, collaborative agreements, and geographic expansion to gain an edge over the competition
• For instance, in October 2019, BabelBark partnered with the Independent Veterinary Practice Association (IVPA), an organization representing the interests of privately owned hospitals in North America. This would allow the company to reach a large customer base of 390 members in 42 states and the local population in their areas

Veterinary Telehealth Market Segmentation

Grand View Research has segmented the global veterinary telehealth market on the basis of animal type, service type, and region:

Veterinary Telehealth Animal Type Outlook (Revenue, USD Million, 2016 - 2028)

• Canine
• Feline
• Equine
• Bovine
• Swine
• Others

Veterinary Telehealth Service Type Outlook (Revenue, USD Million, 2016 - 2028)

• Telemedicine
• Teleconsulting
• Telemonitoring
• Others

Veterinary Telehealth Regional Outlook (Revenue, USD Million, 2016 - 2028)

• North America
  • US.
  • Canada
• Europe
  • Germany
  • UK.
  • France
  • Italy
  • Spain
• Asia Pacific
  • Japan
  • China
  • India
  • Australia
• Latin America
  • Brazil
  • Mexico
  • Argentina
• Middle East and Africa (MEA)
  • Saudi Arabia
  • South Africa

List of Key Players of Veterinary Telehealth Market

• Airvet
• Activ4Pets
• BabelBark, Inc.
• GuardianVets
• PetDesk
• Petzam
• TeleTails
• Televet
• Vetster, Inc.
• VitusVet
• Whiskers Worldwide, LLC
• Virtuwoof, LLC
• FirstVet
• PawSquad
• Petriage Inc.

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Preparative And Process Chromatography Market is Projected to Boost USD 17.26 Billion by 2028

 Preparative And Process Chromatography Market Growth & Trends

The global preparative and process chromatography market size is expected to reach USD 17.26 billion by 2028, according to a new report by Grand View Research, Inc. It is expected to expand at a CAGR of 11.65% from 2021 to 2028. High demand for monoclonal antibodies, coupled with the growing adoption of preparative chromatographic techniques in the bioprocessing industry, is anticipated to boost the revenue growth in the market over the forecast period.

Moreover, an increase in the number of R&D activities in the pharmaceutical and biotechnology industries is driving the adoption of liquid chromatographic techniques in downstream assays, resulting in the anticipated market growth. In addition, technological developments to advance the final product recovery in terms of yield accelerate and augment the uptake of these techniques across various applications.

Furthermore, expanding application of these techniques has propelled the key players to make strategic investments to increase their revenue share in the space. Companies are actively engaged in the development of new products to meet the changing consumer demands. For instance, in November 2020, Shimadzu Corporation launched “Advanced i-Series” HPLC. This is an improved flagship liquid chromatography model to support remote work.

Chromatography columns are gaining increasing attention in the global space. Companies involved in prepacked chromatography columns consistently innovate new products to gain a reputed market share. Moreover, the integration of preparative chromatography in COVID-19 vaccine development has created lucrative opportunities for the key players to capture the untapped avenues of the market.

Preparative chromatographic techniques are anticipated to register the fastest CAGR throughout the forecast period due to the increasing application in medical research and the drug approval process. The food end-use segment is estimated to exhibit the fastest CAGR over the forecast period owing to the high use of analytical techniques for food safety and food authentication assessment.

Request a free sample copy or view report summary: Preparative And Process Chromatography Market Report

Preparative And Process Chromatography Market Report Highlights

• By product, process chromatography accounted for the largest revenue share in 2020 owing to the growing research activities and adoption of automated systems in the field of biopharmaceuticals
• On the basis of type, the liquid chromatographic segment dominated the market in 2020 owing to the high demand for preparative HPLC in the therapeutic development process
• Based on end use, the pharmaceutical segment held the largest share in 2020 owing to increasing application in drug safety assessment as an analytical tool for qualitative and quantitative analysis
• North America dominated the market in 2020 owing to increasing investments in the development of new resin for the isolation and purification of vaccines. Extensive COVID-19 vaccine development efforts in the region have spurred the market growth as the process significantly relies on the use of chromatography for the characterization
• Asia Pacific is projected to witness the fastest growth over the forecast period. The growing biopharmaceutical sector in the region has increased the demand for antibodies and resins. Extensive R&D activities in the Asian pharmaceutical market result in the growing demand for chromatography products

Preparative And Process Chromatography Market Segmentation

Grand View Research has segmented the global preparative and process chromatography market on the basis of product, type, end use, and region:

Preparative And Process Chromatography Product Outlook (Revenue, USD Million, 2017 - 2028)

• Process Chromatography
  • System
    • Multi-use Batch Chromatography Systems
    • Single-use Batch Chromatography Systems
    • Continuous Chromatography Systems   
  • Consumables
    • Reagents
    • Resins
      • Affinity Resins
      • Ion-exchange Resins
      • Size-exclusion Resins
      • Hydrophobic Interaction Resins
      • Reversed Phase Resins
      • Mixed-mode/Multi-mode Resins
    • Columns
      • Prepacked Columns
      • Automated Columns
      • Manual Columns
    • Services
  • Preparative Chromatography
    • System
      • Semi-preparative Chromatography Systems
      • Other Chromatography Systems
    • Consumables
      • Reagents
      • Resins
        • Affinity Resins
        • Ion-exchange Resins
        • Size-exclusion Resins
        • Hydrophobic Interaction Resins
        • Reversed Phase Resins
        • Mixed-mode/Multi-mode Resins
      • Columns
        • Prepacked Columns
        • Empty Columns
      • Services

Preparative And Process Chromatography Type Outlook (Revenue, USD Million, 2017 - 2028)

• Liquid Chromatography
  • HPLC
  • Flash/Column Chromatography
  • Ion-exchange chromatography
  • Size-exclusion chromatography
  • Affinity chromatography
• Gas Chromatography
• Thin Layer Chromatography
• Paper Chromatography
• Gel-permeation (Molecular Sieve) Chromatography
• Hydrophobic Interaction Chromatography

Preparative And Process Chromatography End-use Outlook (Revenue, USD Million, 2017 - 2028)

• Pharmaceutical
• Biotechnology
• Food
• Nutraceutical
• Others

Preparative And Process Chromatography Regional Outlook (Revenue, USD Million, 2017 - 2028)

• North America
  • US.
  • Canada
• Europe
  • Germany
  • UK.
  • France
  • Italy
  • Spain
• Asia Pacific
  • Japan
  • China
  • India
• Latin America
  • Brazil
  • Mexico
• MEA
  • South Africa
  • Saudi Arabia

List of Key Players of Preparative And Process Chromatography Market

• GE Healthcare
• Agilent Technologies
• Danaher Corporation
• Bio-Rad Laboratories Inc.
• Merck KGaA
• Thermo Fisher Scientific Inc.
• Shimadzu Corporation
• Novasep Holding S.A.S
• Waters Corporation

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Complementary & Alternative Medicine Market Poised to Expand at a Robust Pace Over 2028

 

Complementary And Alternative Medicine Market Growth & Trends

The global complementary and alternative medicine market size is expected to reach USD 404.66 billion by 2028, according to a new report by Grand View Research, Inc. It is expected to expand at a CAGR of 22.03% from 2021 to 2028. The market has witnessed a significant expansion in its consumer base in recent years owing to the benefits and philosophies that have the potential to attract customers.

The core philosophies of alternative medicine practices and complementary therapies include high preference to natural products as compared to synthetic ones, avoiding implementation of quick-fix type therapies, ensuring sufficient duration is given for healing, the onset of any illness is attributed to body-imbalance, the body has the ability to heal itself, the whole patient has to be treated and not just a specific diseased body part, and gentle therapies have to be administered before the harsh ones.

The most commonly administered and popular complementary therapies include Alexander technique, acupuncture, herbal medicine, homeopathy, aromatherapy, reiki, naturopathy, and yoga. Profitable business expansion strategies are being adopted by not only market participants but also by medical settings to ensure effective marketing and promotion of alternative medicine therapies.

Yoga, mind, and body-oriented traditional medicines are expected to gain significant traction in the coming years. Expanding applications of yoga and mind healing across chronic ailments, such as cancer, diabetes, COVID-19, and cardiovascular diseases, are set to contribute to the growth of the mind healing intervention segment.

More than half of physicians based in office set-ups in the U.S. have recommended at least one complementary health intervention to their patients, as reported by a survey published in January 2020. Additionally, a large number of female physicians integrate alternative medicine approaches, whereas male physicians most commonly recommend osteopathic manipulation and chiropractic treatment interventions. An increase in the number of such surveys is expected to enable physicians, consumers, and medical schools to gain a better understanding of the potential differences in complementary and alternative medicine use.

Companies are initiating strategic product developments to sustain the market competition. For instance, in July 2019, Colombia Nutritional launched a new process solution having a multi-phase onboarding feature designed for the efficient online launch of the latest products. The key objective of this strategic product development was to maintain minimum order quantity (MOQ) that would further improve the quality of service provided.

Request a free sample copy or view report summary: Complementary And Alternative Medicine Market Report

Complementary And Alternative Medicine Market Report Highlights

• By intervention, traditional alternative medicine or botanicals dominated the market with a share of 38.48% in 2020. Botanicals are among the prominent forms of alternative treatment practices, inclusive of natural and herbal treatment supplements, coupled with therapeutic interventions, incorporating herbs, oils, and other curative supplements
• In the body healing intervention segment, yoga held the largest share of 36.27% in 2020. In the mind healing segment, hypnotherapy is expected to exhibit the fastest CAGR of 22.44% from 2021 to 2028
• Europe held the largest share of 33.35% in 2020 owing to the extended research efforts targeted toward bringing CAM practices to the mainstream medicine
• The Middle East and Africa is expected to expand at the fastest CAGR of 24.78% from 2021 to 2028
• Based on distribution method, distance correspondence and e-sales are expected to witness significant lucrative opportunities in the near future, particularly attributed to the lockdown and social distancing implications associated with the recent pandemic outbreak of COVID-19 across the globe

Complementary And Alternative Medicine Market Segmentation

Grand View Research has segmented the global complementary and alternative medicine market on the basis of intervention, distribution method, and region:

Complementary And Alternative Medicine Intervention Outlook (Revenue, USD Billion, 2017 – 2028)

• Traditional Alternative Medicine/Botanicals
  • Ayurveda
  • Apitherapy
  • Bach Flower Therapy
  • Naturopathic Medicine
  • Traditional Chinese Medicine
  • Traditional Korean Medicine
  • Traditional Japanese Medicine
  • Traditional Mongolian Medicine
  • Traditional Tibetan Medicine
  • Zang Fu Theory
• Mind Healing
  • Autosuggestion
  • Hypnotherapy
  • Neuro-linguistic Programming
  • Self-hypnosis
  • Spiritual Mind Treatment
  • Transcendental Meditation
• Body Healing
  • Acupressure
  • Acupuncture
  • Alexander Technique
  • Auriculotherapy
  • Autogenic Training
  • Chiropractic
  • Cupping Therapy
  • Kinesiology
  • Osteomyology
  • Osteopathy
  • Pilates
  • Qigong
  • Reflexology
  • Yoga
• External Energy
  • Magnetic Therapy
    • Bio-magnetic Therapy
    • Magnetic Resonance Therapy
  • Radionics
  • Reiki
  • Therapeutic Touch
  • Chakra Healing
• Sensory Healing
  • Aromatherapy
  • Music therapy
  • Sonopuncture
  • Sound Therapy

Complementary And Alternative Medicine Distribution Method Outlook (Revenue, USD Billion, 2017 – 2028)

• Direct Sales
• E-sales
• Distance Correspondence

Complementary And Alternative Medicine Regional Outlook (Revenue, USD Billion, 2017 – 2028)

• North America
  • US.
  • Canada
• Europe
  • France
  • Germany
  • Switzerland
  • Austria
  • Spain
  • Norway
  • Denmark
  • Sweden
  • Belgium
  • Netherlands
  • UK.
  • Ireland
• Asia Pacific
  • Japan
  • China
  • India
  • Australia
  • Hong Kong
  • Singapore
  • New Zealand
• Latin America
  • Brazil
  • Mexico
  • Argentina
• Middle East & Africa
  • Israel
  • UAE
  • South Africa

List of Key Players of Complementary And Alternative Medicine Market

• Columbia Nutritional
• Herb Pharm
• Herbal Hills
• Ramamani Iyengar Memorial Yoga Institute
• John Schumacher Unity Woods Yoga Centre
• Yoga Tree Studios, Inc.
• Helio USA Inc.
• NatureKue
• Nordic Nutraceuticals
• Pure encapsulations, LLC.
• The Healing Company Ltd.
• Quantum-Touch
• BIOTAILOR
• Bikram Yoga
• True Yoga
• Amrita Ayurveda & Yoga
• AYUSH Ayurvedic Pte Ltd.
• Sheng Chang Pharmaceutical Company
• LKK Health Products Group Limited
• Body & Soul Yoga Club
• Namat Fitness Management (Shanghai) Co., Ltd. (Y+)
• ALCES LLP

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Next-Generation Sequencing Data Analysis Market is Estimated To Attain USD 1.72 Billion by 2028

 Next-Generation Sequencing Data Analysis Market Growth & Trends

The global next-generation sequencing data analysis market size is expected to reach USD 1.72 billion by 2028 registering a CAGR of 15.02%, according to a new report by Grand View Research, Inc. Key drivers contributing to market expansion include the growing adoption of sequencing platforms for clinical diagnosis because of a significant reduction in the cost of installation. The easy availability of genomic and proteomic data is also expected to create lucrative growth opportunities in this market during the forecast period.

In addition, a decrease in the cost of sequencing is expected to increase the adoption of next-generation sequencing (NGS), which, in turn, is likely to boost the market growth. Availability of tools, such as Agilent’s HaloPlex capture system and Targeted Methyl-Seq platform from EpiGentek Group Inc., has helped in the determination of DNA methylation profiles in individual genomes. An increase in the adoption of bisulfite-methylation for targeted sequencing and targeted methylation NGS data analysis methods is anticipated to propel market growth.

EpigenDx, CD Genomics, Novogene Co., Ltd., and Epigentek Group, Inc. are the key players that offer methylation sequencing and targeted bisulfite sequencing data analysis services. The launch of new products will further boost revenue generation in the market. Major market participants have undertaken various strategic initiatives to strengthen their position in the market. For instance, in January 2021, Transnetyx, Inc. collaborated with One Codex to provide end-to-end analysis and microbiome sequencing services. This is expected to offer affordable sequencing analysis services to researchers.

Request a free sample copy or view report summary: Next-Generation Sequencing Data Analysis Market Report

Next-Generation Sequencing Data Analysis Market Report Highlights

• Services dominated the products segment in 2020 and will retain the leading position growing at the fastest CAGR during the forecast period
• Although NGS is advantageous in terms of affordability and speed, many research entities are unable to adopt it owing to a lack of sufficient computational infrastructure and skilled professionals to analyze the generated information
• Therefore, institutions that lack provision for data interpretation, analysis, and management adopt platforms & services offered by other companies in the market
• Tertiary analysis occupied a major portion of the revenue generated by the workflow segment as it accounts for the most complex and important step of Next-Generation Sequencing, which is directly linked with the interpretation of results
• In-house mode dominated the market in 2020 and is expected to maintain its dominance during the forecast period
• However, the outsourced mode is expected to register the fastest CAGR from 2021 to 2028 owing to the time and cost benefits associated with this mode and the presence of key players offering data analysis services
• The short-read sequencing segment led the global market in 2020 due to the wide adoption of these techniques as they are inexpensive and can work with fragment DNA along with the availability of several tools and algorithms
• The academic research end-use segment generated the largest revenue in 2020; however, clinical research is estimated to be the fastest-growing segment from 2021 to 2028
• North America dominated the global market in 2020 owing to the launch of large-scale genome sequencing projects and the rise in demand for personalized medicine

Next-Generation Sequencing Data Analysis Market Segmentation

Grand View Research has segmented the global next-generation sequencing data analysis market on the basis of product, workflow, mode, read length, end-use, and region:

Next-Generation Sequencing Data Analysis Product Outlook (Revenue, USD Million, 2017 - 2028)

• Services
• NGS Commercial Software
  • Platform OS/UI
  • Analytical Software
    • Alignment Tools & Software
      • DNA Seq Alignment
      • RNA Seq Alignment
      • Protein Seq Alignment
    • QC/Pre-processing Tools
    • Others

Next-Generation Sequencing Data AnalysisWorkflow Outlook (Revenue, USD Million, 2017 - 2028)

• Primary
• Secondary
  • Read Mapping
  • Variant Alignment & Variant Calling
• Tertiary
  • Variant Annotation
  • Application-specific
    • Targeted Sequencing/Gene Panel
    • Exome Sequencing
    • RNA Sequencing
    • Whole Genome Sequencing
    • ChIP-sequencing
    • Others

Next-Generation Sequencing Data AnalysisMode Outlook (Revenue, USD Million, 2017 - 2028)

• In-house
• Outsourced

Next-Generation Sequencing Data AnalysisRead Length Outlook (Revenue, USD Million, 2017 - 2028)

• Short Read
• Long Read
• Very Long Read

Next-Generation Sequencing Data AnalysisEnd-use Outlook (Revenue, USD Million, 2017 - 2028)

• Academic Research
• Clinical Research
• Hospitals & Clinics
• Pharma & Biotech Entities
• Other Users

Next-Generation Sequencing Data Analysis Regional Outlook (Revenue, USD Million, 2017 - 2028)

• North America
  • US.
  • Canada
• Europe
  • Germany
  • UK.
  • France
  • Italy
  • Spain
• Asia Pacific
  • Japan
  • China
  • India
  • Australia
  • South Korea
• Latin America
  • Brazil
  • Mexico
• Middle East Africa (MEA)
  • South Africa
  • Saudi Arabia

List of Key Players of Next-Generation Sequencing (NGS) Data Analysis Market

• Thermo Fisher Scientific, Inc.
• QIAGEN
• Illumina, Inc.
• Hoffmann-La Roche Ltd.
• Agilent Technologies, Inc.
• Bio-Rad Laboratories, Inc.
• PierianDx
• Intrexon Bioinformatics Germany GmbH
• Partek, Inc.
• Eurofins Scientific
• Pacific Biosciences of California, Inc.
• DNASTAR, Inc.
• Congenica Ltd.
• Fabric Genomics, Inc.
• Genuity Science
• DNAnexus Inc.
• SciGenom Labs Pvt. Ltd.
• Golden Helix, Inc.

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

mHealth Market Emerging Trends , Industry Growth At Regional Level And Forecast Till 2028: Grand View Research Inc.

 

mHealth Market Growth & Trends

The global mHealth market size is expected to reach USD 166.2 billion by 2028 and is expected to expand at a CAGR of 17.6% over the forecast period, according to a new report by Grand View Research, Inc. Growing penetration of smartphones & internet connectivity, rising adoption of mHealth platforms and technologies by patients and physicians, and supportive government initiatives are among the key factors driving the market growth. Rising demand for preventive healthcare and increasing funding for the mHealth startups are also projected to propel the market growth.

In addition, the Covid-19 pandemic has led to increased utilization of mHealth technologies due to increased adoption of remote patient monitoring and diagnosis & analysis of patient data. For instance, according to data published by Statista, the number of medical apps downloaded during the peak months of the pandemic as compared to the number of downloads in January 2020 demonstrated a considerable spike. In India, in particular, there was around a 90% increase in the medical apps' downloads during the peak months of the pandemic.

Based on participants, mobile operators accounted for the highest revenue share in the market owing to improvements in the network infrastructure, increase in the use of 4G & 3G technologies, and rise in the number of mobile subscribers. A rise in the number of industry partnerships is another significant factor driving the segment growth. For instance, in 2019, OneLife, a mobile medical software company, partnered with AT&T for the development of a health-tracking watch to monitor a patient’s heart rate, location, sleep, and movement.

North America dominated the global market with a revenue share of over 38% in 2020 owing to various factors including high healthcare expenditure, increased geriatric population, high prevalence of chronic diseases, and improved network infrastructure. Favorable government initiatives and increasing adoption of mobile health apps are anticipated to the regional market during the forecast period.

Request a free sample copy or view report summary: mHealth Market Report

mHealth Market Report Highlights

• mHealth apps segment dominated the market in 2020 owing to increased penetration of smartphones & the internet and high awareness levels about mobile health applications among healthcare professionals
• The segment will expand further at the fastest CAGR from 2021 to 2028 due to the growing adoption and visibility of such apps to create affirmative health outcomes along with the rising preference for mobile apps by healthcare professionals and patients
• The monitoring services segment dominated the market in 2020 owing to increased incidence of chronic diseases and demand for remote monitoring systems in post-acute care and independent aging solutions
• Increased number of market players investing in mHealth services for patient monitoring is also expected to propel the segment
• Monitoring services primarily involve the observation of diseases, health conditions, or other critical medical parameters for a defined time

mHealth Market Segmentation

Grand View Research has segmented the global mHealth market on the basis of component, services, participants, and region:

mHealth Component Outlook (Revenue, USD Million, 2016 - 2028)

• Wearables
  • BP Monitors
  • Glucose Meters
  • Pulse Oximeters
  • Sleep Apnea Monitors (PSG)
  • Neurological Monitors
  • Activity Trackers/Actigraphs
• mHealth Apps
  • Medical Apps
    • Women’s Health
    • Personal Health Record Apps
    • Medication Management Apps
    • Disease Management Apps
    • Diagnostic Apps
    • Remote Monitoring Apps
    • Others
  • Fitness Apps
    • Exercise & Fitness
    • Diet & Nutrition
    • Lifestyle & Stress

mHealth Services Outlook (Revenue, USD Million, 2016 - 2028)

• Monitoring Services
  • Independent Aging Solutions
  • Chronic Disease Management & Post-acute Care Services
• Diagnosis Services
• Healthcare Systems Strengthening Services
• Others

mHealth Participants Outlook (Revenue, USD Million, 2016 - 2028)

• Mobile Operators
• Device Vendors
• Content Players
• Healthcare Providers

mHealth Regional Outlook (Revenue, USD Million, 2016 - 2028)

• North America
  • US.
  • Canada
• Europe
  • UK.
  • Germany
  • Spain
  • France
  • Italy
  • Russia
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Singapore
  • Australia
• Latin America
  • Brazil
  • Mexico
  • Argentina
• Middle East Africa
  • South Africa
  • Saudi Arabia
  • UAE

List of Key Players of mHealth Market

• AT&T
• Telefonica S.A.
• SoftServe
• Google, Inc.
• Airstrip Technologies, Inc.
• Samsung Electronics Co. Ltd.
• Allscripts Healthcare Solutions
• Apple, Inc.
• Orange
• mQure
• Qualcomm Technologies, Inc.
• Vodafone Group

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.